全文获取类型
收费全文 | 2043篇 |
免费 | 95篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 39篇 |
妇产科学 | 82篇 |
基础医学 | 357篇 |
口腔科学 | 14篇 |
临床医学 | 202篇 |
内科学 | 390篇 |
皮肤病学 | 19篇 |
神经病学 | 200篇 |
特种医学 | 73篇 |
外科学 | 362篇 |
综合类 | 8篇 |
预防医学 | 102篇 |
眼科学 | 45篇 |
药学 | 104篇 |
中国医学 | 19篇 |
肿瘤学 | 105篇 |
出版年
2022年 | 19篇 |
2021年 | 47篇 |
2020年 | 22篇 |
2019年 | 34篇 |
2018年 | 51篇 |
2017年 | 29篇 |
2016年 | 23篇 |
2015年 | 54篇 |
2014年 | 58篇 |
2013年 | 70篇 |
2012年 | 115篇 |
2011年 | 123篇 |
2010年 | 49篇 |
2009年 | 45篇 |
2008年 | 97篇 |
2007年 | 100篇 |
2006年 | 114篇 |
2005年 | 110篇 |
2004年 | 104篇 |
2003年 | 101篇 |
2002年 | 99篇 |
2001年 | 46篇 |
2000年 | 48篇 |
1999年 | 39篇 |
1998年 | 20篇 |
1997年 | 14篇 |
1996年 | 16篇 |
1995年 | 18篇 |
1992年 | 28篇 |
1991年 | 38篇 |
1990年 | 27篇 |
1989年 | 32篇 |
1988年 | 35篇 |
1987年 | 35篇 |
1986年 | 21篇 |
1985年 | 37篇 |
1984年 | 21篇 |
1983年 | 24篇 |
1982年 | 10篇 |
1981年 | 13篇 |
1980年 | 13篇 |
1979年 | 31篇 |
1977年 | 8篇 |
1975年 | 7篇 |
1974年 | 11篇 |
1973年 | 8篇 |
1972年 | 14篇 |
1970年 | 8篇 |
1969年 | 9篇 |
1968年 | 9篇 |
排序方式: 共有2149条查询结果,搜索用时 15 毫秒
51.
52.
53.
Danuta M. Bukowska Avenell L. Chew Emily Huynh Irwin Kashani Sue Ling Wan Pak Ming Wan Fred K Chen 《Biomedical optics express》2015,6(12):4676-4693
A large number of human retinal diseases are characterized by a progressive loss of cones, the photoreceptors critical for visual acuity and color perception. Adaptive Optics (AO) imaging presents a potential method to study these cells in vivo. However, AO imaging in ophthalmology is a relatively new phenomenon and quantitative analysis of these images remains difficult and tedious using manual methods. This paper illustrates a novel semi-automated quantitative technique enabling registration of AO images to macular landmarks, cone counting and its radius quantification at specified distances from the foveal center. The new cone counting approach employs the circle Hough transform (cHT) and is compared to automated counting methods, as well as arbitrated manual cone identification. We explore the impact of varying the circle detection parameter on the validity of cHT cone counting and discuss the potential role of using this algorithm in detecting both cones and rods separately.OCIS codes: (100.0100) Image processing, (170.3880) Medical and biological imaging, (110.1080) Active or adaptive optics, (170.4470) Ophthalmology 相似文献
54.
55.
The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia 总被引:6,自引:0,他引:6 下载免费PDF全文
Junge CE Sugawara T Mannaioni G Alagarsamy S Conn PJ Brat DJ Chan PH Traynelis SF 《Proceedings of the National Academy of Sciences of the United States of America》2003,100(22):13019-13024
The serine proteases tissue plasminogen activator, plasmin, and thrombin and their receptors have previously been suggested to contribute to neuronal damage in certain pathological situations. Here we demonstrate that mice lacking protease-activated receptor 1 (PAR1) have a 3.1-fold reduction in infarct volume after transient focal cerebral ischemia. Intracerebroventricular injection of PAR1 antagonist BMS-200261 reduced infarct volume 2.7-fold. There are no detectable differences between PAR1-/- and WT mice in cerebrovascular anatomy, capillary density, or capillary diameter, demonstrating that the neuroprotective phenotype is not likely related to congenital abnormalities in vascular development. We also show that the exogenously applied serine proteases thrombin, plasmin, and tissue plasminogen activator can activate PAR1 signaling in brain tissue. These data together suggest that if blood-derived serine proteases that enter brain tissue in ischemic situations can activate PAR1, this sequence of events may contribute to the harmful effects observed. Furthermore, PAR1 immunoreactivity is present in human brain, suggesting that inhibition of PAR1 may provide a novel potential therapeutic strategy for decreasing neuronal damage associated with ischemia and blood-brain barrier breakdown. 相似文献
56.
Tam LS Li EK Leung VY Griffith JF Benzie IF Lim PL Whitney B Lee VW Lee KK Thomas GN Tomlinson B 《The Journal of rheumatology》2005,32(2):275-282
OBJECTIVE: Patients with systemic lupus erythematosus (SLE) experience excess morbidity and mortality due to coronary artery disease (CAD) that cannot be fully explained by the classical CAD risk factors. Among emerging CAD risk factors, oxidative stress is currently being emphasized. We evaluated the effects of longterm antioxidant vitamins on markers of oxidative stress and antioxidant defense and endothelial function in 39 patients with SLE. METHODS: Patients were randomized to receive either placebo or vitamins (500 mg vitamin C and 800 IU vitamin E daily) for 12 weeks. Markers of oxidative stress included malondialdehyde (MDA) and allantoin. Antioxidants measured included erythrocyte superoxide dismutase and glutathione peroxidase, plasma total antioxidant power (as FRAP value), and ascorbic acid and vitamin E concentrations. Endothelial function was assessed by flow-mediated dilatation (FMD) of the brachial artery and plasma concentration of von Willebrand factor (vWF) and plasminogen activator inhibitor type 1 (PAI-1). Primary outcome of the study included the change in lipid peroxidation as revealed by MDA levels. Secondary outcomes included changes in allantoin and antioxidant levels and change in endothelial function. RESULTS: After treatment, plasma ascorbic acid and alpha-tocopherol concentrations were significantly (p < 0.05) increased only in the vitamin-treated group, associated with a significant decrease (p < 0.05) in plasma MDA. Other oxidative stress markers and antioxidant levels remained unchanged in both groups. FMD and vWF and PAI-1 levels remained unchanged in both groups. CONCLUSION: Combined administration of vitamins C and E was associated with decreased lipid peroxidation, but did not affect endothelial function in patients with SLE after 3 months of therapy. 相似文献
57.
58.
Rong Liu Stephanie Curry Patricia McMonagle Wendy W. Yeh Steven W. Ludmerer Patricia A. Jumes William L. Marshall Stephanie Kong Paul Ingravallo Stuart Black Irene Pak Mark J. DiNubile Anita Y. M. Howe 《Antimicrobial agents and chemotherapy》2015,59(11):6922-6929
Elbasvir is an investigational NS5A inhibitor with in vitro activity against multiple HCV genotypes. Antiviral activity of elbasvir was measured in replicons derived from wild-type or resistant variants of genotypes 1a, 1b, and 3. The barrier to resistance was assessed by the number of resistant colonies selected by exposure to various elbasvir concentrations. In a phase 1b dose-escalating study, virologic responses were determined in 48 noncirrhotic adult men with chronic genotype 1 or 3 infections randomized to placebo or elbasvir from 5 to 50 mg (genotype 1) or 10 to 100 mg (genotype 3) once daily for 5 days. The NS5A gene was sequenced from plasma specimens obtained before, during, and after treatment. Elbasvir suppressed the emergence of resistance-associated variants (RAVs) in vitro in a dose-dependent manner. Variants selected by exposure to high elbasvir concentrations typically encoded multiple amino acid substitutions (most commonly involving loci 30, 31, and 93), conferring high-level elbasvir resistance. In the monotherapy study, patients with genotype 1b had greater reductions in HCV RNA levels than patients with genotype 1a at all elbasvir doses; responses in patients with genotype 3 were generally less pronounced than for genotype 1, particularly at lower elbasvir doses. M28T, Q30R, L31V, and Y93H in genotype 1a, L31V and Y93H in genotype 1b, and A30K, L31F, and Y93H in genotype 3 were the predominant RAVs selected by elbasvir monotherapy. Virologic findings in patients were consistent with the preclinical observations. NS5A-RAVs emerged most often at amino acid positions 28, 30, 31, and 93 in both the laboratory and clinical trial. (The MK-8742 P002 trial has been registered at ClinicalTrials.gov under identifier .) NCT01532973相似文献
59.
60.
Tang KH Ma S Lee TK Chan YP Kwan PS Tong CM Ng IO Man K To KF Lai PB Lo CM Guan XY Chan KW 《Hepatology (Baltimore, Md.)》2012,55(3):807-820
A novel theory in the field of tumor biology postulates that cancer growth is driven by a population of stem-like cells, called tumor-initiating cells (TICs). We previously identified a TIC population derived from hepatocellular carcinoma (HCC) that is characterized by membrane expression of CD133. Here, we describe a novel mechanism by which these cells mediate tumor growth and angiogenesis by systematic comparison of the gene expression profiles between sorted CD133 liver subpopulations through genome-wide microarray analysis. A significantly dysregulated interleukin-8 (IL-8) signaling network was identified in CD133(+) liver TICs obtained from HCC clinical samples and cell lines. IL-8 was found to be overexpressed at both the genomic and proteomic levels in CD133(+) cells isolated from HCC cell lines or clinical samples. Functional studies found enhanced IL-8 secretion in CD133(+) liver TICs to exhibit a greater ability to self-renew, induce tumor angiogenesis, and initiate tumors. In further support of these observations, IL-8 repression in CD133(+) liver TICs by knockdown or neutralizing antibody abolished these effects. Subsequent studies of the IL-8 functional network identified neurotensin (NTS) and CXCL1 to be preferentially expressed in CD133(+) liver TICs. Addition of exogenous NTS resulted in concomitant up-regulation of IL-8 and CXCL1 with simultaneous activation of p-ERK1/2 and RAF-1, both key components of the mitogen-activated protein kinase (MAPK) pathway. Enhanced IL-8 secretion by CD133(+) liver TICs can in turn activate an IL-8-dependent feedback loop that signals through the MAPK pathway. Further, in its role as a liver TIC marker CD133 also plays a functional part in regulating tumorigenesis of liver TICs by way of regulating NTS, IL-8, CXCL1, and MAPK signaling. CONCLUSION: CD133(+) liver TICs promote angiogenesis, tumorigenesis, and self-renewal through NTS-induced activation of the IL-8 signaling cascade. 相似文献